Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The conversation discusses switching from finasteride to dutasteride for hair loss treatment, as some users report no improvement with finasteride after several months. Many suggest patience, as results can take over a year, while others recommend trying dutasteride for potentially better outcomes.

Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.

The conversation discusses a personal theory on the role of DHT in stress and reproduction, suggesting it converts testosterone for reproductive traits. The discussion includes skepticism and mentions individual differences in physiology and neurochemistry.

The conversation discusses a user's hesitation to start dutasteride for hair loss while already using finasteride, minoxidil (both oral and topical), RU58841, and ketoconazole shampoo. The user plans to gradually transition from finasteride to dutasteride to minimize shedding, seeking advice and reassurance from others.

A user experienced hair thinning and scalp issues after using a sebum-regulating shampoo and perm treatments. They are advised to consider potential allergies, try a simple shampoo, and research treatments like finasteride for possible male pattern baldness.

The user experiences immediate hair shedding linked to stress, unlike typical telogen effluvium, and is seeking answers. A suggestion was made to use spironolactone and topical minoxidil to address potential DHT-related shedding.

Sugary beverages increase the risk of pattern hair loss in men by 57%. Treatments discussed include Minoxidil, finasteride, and RU58841.

Anti-androgens like Finasteride, Dutasteride, Metformin, and Topical Spironolactone cause hairline recession and increased cholesterol levels. The hairline recovers after stopping the drugs.

Microneedling can cause a sneezing reflex due to tingling in the nose. Users report this reaction, especially in the temple region.

GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.

Genetics mainly cause hair loss, but diet, stress, smoking, and alcohol can worsen it. Treatments include finasteride, minoxidil, and lifestyle changes like a healthy diet and avoiding caffeine.

An SSRI (paroxetine) reduced hair loss and itching for a user with male-pattern baldness, but liver issues forced discontinuation, leading to increased hair loss and anxiety. The user plans to try other anti-anxiety medications, noting stress and anxiety significantly impact hair loss.

A medical student experienced hair loss slowing with Finasteride but developed severe, treatment-resistant insomnia. They tried various medications with little effect, suspecting Post-Finasteride Syndrome, and others suggested the insomnia might be linked to Finasteride's impact on neurosteroids.

Various hair growth treatments were discussed, including microneedling, bimatoprost, setipiprant, stemoxydine, PGE2, CB-03-01, WNT Beta-Catenin upregulators, KY19382, topical estrogen, IGF-1, GH, MK-677, oral castor oil, fisetin, resveratrol, cetrizine, and lactic acid. Users shared experiences and sources for these treatments, with some expressing interest in topical solutions and others noting the lack of FDA approval or scientific evidence for certain options.

Accutane can cause hair thinning in some users, with effects varying from no change to permanent hair loss. Some users reported improvements in hair and skin with treatments like Finasteride, while others experienced severe side effects, including mental health issues.

The user has been managing hair loss for over 15 years, using treatments like Minoxidil, Finasteride, and corticosteroids, while experiencing side effects and recurrent Alopecia Areata. They seek advice on progression and potential underlying conditions, questioning if their hair loss is due to an autoimmune issue beyond typical patterns.

The user has been experiencing hair loss despite using finasteride and dutasteride, with recent photos showing significant thinning. They are considering increasing their dutasteride dosage and possibly trying microneedling, while also addressing concerns about diet and nutrient deficiencies.

Minoxidil, specifically Rogaine, is discussed as an effective treatment for hair regrowth, with some users experiencing positive results and others finding it inconvenient. Users also mention the effectiveness of liquid Rogaine over other forms and note that results can vary.

Switching from finasteride to dutasteride often causes increased hair shedding initially. Dutasteride is stronger but takes longer to show results, leading to concerns about worsening hair loss during the transition.

The user experienced significant hair improvement using oral finasteride and minoxidil but is now facing a secondary hair shedding phase after nine months, possibly linked to weight loss or seasonal changes. Despite concerns, others in the conversation suggest that such shedding is normal and temporary.

A 16-year-old shared progress pictures after 68 days of using 5% topical minoxidil for hair growth. The conversation focused on confusion about the order of before-and-after photos, with some users commenting on the effectiveness and others on the user's young age and genetics.

Exosome therapy for hair loss is questioned, with microneedling and topical minoxidil/dutasteride being more supported treatments. Concerns are raised about testosterone therapy affecting hair loss, and the lack of standardization and approval for exosome products.

The user experienced significant hair shedding after 1.5 years on dutasteride and oral minoxidil, possibly due to a shedding cycle or lifestyle changes like nicotine use and creatine. Opinions vary on whether creatine contributes to hair loss, with some attributing shedding to synchronized hair cycles or genetic factors.

A 31-year-old is concerned about rapid hair loss before their wedding in 9 weeks, currently using 1mg finasteride and 3.75mg minoxidil daily. Suggestions include accepting the current situation, using hair powders for density, and considering dutasteride after the wedding.

The conversation is about a user experiencing hair loss and discussing their 4.5-month treatment with 2.5mg Minoxidil and 1mg Finasteride. The user is advised to give the treatment more time, consider additional options like topical Minoxidil or microneedling, and possibly consult a dermatologist for further diagnosis.

The user experienced improved hair quality after using oral minoxidil 2.5 mg, finasteride 1 mg, and ketoconazole shampoo. They initially faced heart palpitations with oral minoxidil and had a history of depression with finasteride but found the current regimen effective and manageable.

Some users experienced better results with finasteride after switching from dutasteride, despite dutasteride being stronger. Side effects and continued hair shedding were common issues with dutasteride, leading some to revert to finasteride.

Finasteride caused depression and suicidal thoughts in OP's husband, leading him to stop the medication. He is seeing a doctor for a full hormone panel and psychiatric referral to address these issues.

A 19-year-old male is experiencing hair shedding while using oral minoxidil, ketoconazole, dermastamping, and saw palmetto, and is considering switching to finasteride for better results. Users suggest that saw palmetto may not be effective and recommend finasteride instead, while also discussing other treatments like rosemary oil, peppermint oil, and pumpkin seed oil.

A 43-year-old male is using oral and topical minoxidil and oral finasteride to address hair loss, experiencing minimal shedding and side effects, but noticing increased facial hair growth. He plans to reduce the topical minoxidil application and continue the regimen for a year to evaluate its effectiveness.